Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44,524 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Advances in vitiligo: Update on therapeutic targets.
Feng Y, Lu Y. Feng Y, et al. Among authors: lu y. Front Immunol. 2022 Aug 31;13:986918. doi: 10.3389/fimmu.2022.986918. eCollection 2022. Front Immunol. 2022. PMID: 36119071 Free PMC article. Review.
PD-Ls-PD-1 axis in autoimmune skin diseases.
Feng Y, Lu Y. Feng Y, et al. Among authors: lu y. Int J Dermatol. 2023 Feb;62(2):e85-e87. doi: 10.1111/ijd.16210. Epub 2022 Jun 2. Int J Dermatol. 2023. PMID: 35652606 No abstract available.
A novel reverse perilesional home phototherapy can promote the repigmentation of vitiligo patches with complete leukotrichia: A 12-week, open-label, double-arm, multicenter, randomized clinical trial.
Lei N, Cao X, Feng Y, Liu G, Feng J, Zhao Y, Zhao Z, Li Z, Song L, Lu Y. Lei N, et al. Among authors: lu y. Photodermatol Photoimmunol Photomed. 2024 May;40(3):e12974. doi: 10.1111/phpp.12974. Photodermatol Photoimmunol Photomed. 2024. PMID: 38728444 Clinical Trial.
44,524 results
You have reached the last available page of results. Please see the User Guide for more information.